Assessing mean apnea-hypopnea duration (MAD) in patients with OSA yields hypoxemia and symptom burden data not provided by the AHI or ODI.
Native American vs non-Native individuals showed a higher prevalence and incidence of statin-associated anti-HMHCR antibody IMNM.